ID   HPRT_HUMAN              Reviewed;         218 AA.
AC   P00492; A6NHF0; B2R8M9;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   10-MAY-2017, entry version 198.
DE   RecName: Full=Hypoxanthine-guanine phosphoribosyltransferase;
DE            Short=HGPRT;
DE            Short=HGPRTase;
DE            EC=2.4.2.8;
GN   Name=HPRT1; Synonyms=HPRT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=6300847; DOI=10.1073/pnas.80.2.477;
RA   Jolly D.J., Okayama H., Berg P., Esty A.C., Filpula D., Bohlen P.,
RA   Johnson G.G., Shively J.E., Hunkapillar T., Friedmann T.;
RT   "Isolation and characterization of a full-length expressible cDNA for
RT   human hypoxanthine phosphoribosyl transferase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 80:477-481(1983).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2341149; DOI=10.1016/0888-7543(90)90493-E;
RA   Edwards A., Voss H., Rice P., Civitello A., Stegemann J., Schwager C.,
RA   Zimmermann J., Erfle H., Caskey C.T., Ansorge W.;
RT   "Automated DNA sequencing of the human HPRT locus.";
RL   Genomics 6:593-608(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 2-218, CLEAVAGE OF INITIATOR METHIONINE, AND
RP   ACETYLATION AT ALA-2.
RX   PubMed=7107641;
RA   Wilson J.M., Tarr G.E., Mahoney W.C., Kelley W.N.;
RT   "Human hypoxanthine-guanine phosphoribosyltransferase. Complete amino
RT   acid sequence of the erythrocyte enzyme.";
RL   J. Biol. Chem. 257:10978-10985(1982).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-9.
RX   PubMed=3023844; DOI=10.1128/MCB.6.2.393;
RA   Patel P.I., Framson P.E., Caskey C.T., Chinault A.C.;
RT   "Fine structure of the human hypoxanthine phosphoribosyltransferase
RT   gene.";
RL   Mol. Cell. Biol. 6:393-403(1986).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-115, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) IN COMPLEX WITH GMP.
RX   PubMed=8044844; DOI=10.1016/0092-8674(94)90301-8;
RA   Eads J.C., Scapin G., Xu Y., Grubmeyer C., Sacchettini J.C.;
RT   "The crystal structure of human hypoxanthine-guanine
RT   phosphoribosyltransferase with bound GMP.";
RL   Cell 78:325-334(1994).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH A
RP   TRANSITION-STATE ANALOG.
RX   PubMed=10360366; DOI=10.1038/9376;
RA   Shi W., Li C.M., Tyler P.C., Furneaux R.H., Grubmeyer C.,
RA   Schramm V.L., Almo S.C.;
RT   "The 2.0 A structure of human hypoxanthine-guanine
RT   phosphoribosyltransferase in complex with a transition-state analog
RT   inhibitor.";
RL   Nat. Struct. Biol. 6:588-593(1999).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF MUTANT ALA-69 IN COMPLEX WITH
RP   PHOSPHORIBOSYLPYROPHOSPHATE; MAGNESIUM IONS AND HYPOXANTHINE ANALOG
RP   HPP, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF
RP   LYS-69, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=10338013; DOI=10.1110/ps.8.5.1023;
RA   Balendiran G.K., Molina J.A., Xu Y., Torres-Martinez J., Stevens R.,
RA   Focia P.J., Eakin A.E., Sacchettini J.C., Craig S.P. III;
RT   "Ternary complex structure of human HGPRTase, PRPP, Mg2+, and the
RT   inhibitor HPP reveals the involvement of the flexible loop in
RT   substrate binding.";
RL   Protein Sci. 8:1023-1031(1999).
RN   [18]
RP   REVIEW ON VARIANTS.
RX   PubMed=1487231; DOI=10.1007/BF00220062;
RA   Sculley D.G., Dawson P.A., Emmerson B.T., Gordon R.B.;
RT   "A review of the molecular basis of hypoxanthine-guanine
RT   phosphoribosyltransferase (HPRT) deficiency.";
RL   Hum. Genet. 90:195-207(1992).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF APOPROTEIN, AND SUBUNIT.
RX   PubMed=15990111; DOI=10.1016/j.jmb.2005.05.061;
RA   Keough D.T., Brereton I.M., de Jersey J., Guddat L.W.;
RT   "The crystal structure of free human hypoxanthine-guanine
RT   phosphoribosyltransferase reveals extensive conformational plasticity
RT   throughout the catalytic cycle.";
RL   J. Mol. Biol. 351:170-181(2005).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) IN COMPLEXES WITH ACYCLIC
RP   NUCLEOSIDE PHOSPHONATES, AND CATALYTIC ACTIVITY.
RX   PubMed=19527031; DOI=10.1021/jm900267n;
RA   Keough D.T., Hockova D., Holy A., Naesens L.M., Skinner-Adams T.S.,
RA   Jersey J., Guddat L.W.;
RT   "Inhibition of hypoxanthine-guanine phosphoribosyltransferase by
RT   acyclic nucleoside phosphonates: a new class of antimalarial
RT   therapeutics.";
RL   J. Med. Chem. 52:4391-4399(2009).
RN   [21]
RP   VARIANT GOUT-HPRT TORONTO GLY-51.
RX   PubMed=6853490;
RA   Wilson J.M., Kobayashi R., Fox I.H., Kelley W.N.;
RT   "Human hypoxanthine-guanine phosphoribosyltransferase.";
RL   J. Biol. Chem. 258:6458-6460(1983).
RN   [22]
RP   VARIANT LNS KINSTON ASN-194.
RX   PubMed=6853716; DOI=10.1172/JCI110884;
RA   Wilson J.M., Kelley W.N.;
RT   "Molecular basis of hypoxanthine-guanine phosphoribosyltransferase
RT   deficiency in a patient with the Lesch-Nyhan syndrome.";
RL   J. Clin. Invest. 71:1331-1335(1983).
RN   [23]
RP   VARIANT GOUT-HPRT LONDON LEU-110.
RX   PubMed=6572373; DOI=10.1073/pnas.80.3.870;
RA   Wilson J.M., Tarr G.E., Kelley W.N.;
RT   "Human hypoxanthine (guanine) phosphoribosyltransferase: an amino acid
RT   substitution in a mutant form of the enzyme isolated from a patient
RT   with gout.";
RL   Proc. Natl. Acad. Sci. U.S.A. 80:870-873(1983).
RN   [24]
RP   VARIANT GOUT-HPRT MUNICH ARG-104.
RX   PubMed=6706936;
RA   Wilson J.M., Kelley W.N.;
RT   "Human hypoxanthine-guanine phosphoribosyltransferase. Structural
RT   alteration in a dysfunctional enzyme variant (HPRTMunich) isolated
RT   from a patient with gout.";
RL   J. Biol. Chem. 259:27-30(1984).
RN   [25]
RP   VARIANT GOUT-HPRT MUNICH ARG-104.
RX   PubMed=3358423;
RA   Cariello N.F., Scott J.K., Kat A.G., Thilly W.G., Keohavong P.;
RT   "Resolution of a missense mutant in human genomic DNA by denaturing
RT   gradient gel electrophoresis and direct sequencing using in vitro DNA
RT   amplification: HPRT Munich.";
RL   Am. J. Hum. Genet. 42:726-734(1988).
RN   [26]
RP   VARIANT LNS FLINT LEU-74.
RX   PubMed=3384338; DOI=10.1016/0378-1119(88)90536-7;
RA   Davidson B.L., Pashmforoush M., Kelly W.N., Palella T.D.;
RT   "Genetic basis of hypoxanthine guanine phosphoribosyltransferase
RT   deficiency in a patient with the Lesch-Nyhan syndrome (HPRTFlint).";
RL   Gene 63:331-336(1988).
RN   [27]
RP   VARIANT LNS MIDLAND ASP-130.
RX   PubMed=3265398; DOI=10.1016/0378-1119(88)90601-4;
RA   Davidson B.L., Palella T.D., Kelly W.N.;
RT   "Human hypoxanthine-guanine phosphoribosyltransferase: a single
RT   nucleotide substitution in cDNA clones isolated from a patient with
RT   Lesch-Nyhan syndrome (HPRTMidland).";
RL   Gene 68:85-91(1988).
RN   [28]
RP   VARIANT GOUT-HPRT MET-132.
RX   PubMed=2896620; DOI=10.1007/BF00291707;
RA   Fujimori S., Hidaka Y., Davidson B.L., Palella T.D., Kelley W.N.;
RT   "Identification of a single nucleotide change in a mutant gene for
RT   hypoxanthine-guanine phosphoribosyltransferase (HPRT Ann Arbor).";
RL   Hum. Genet. 79:39-43(1988).
RN   [29]
RP   VARIANT GOUT-HPRT LONDON LEU-110.
RX   PubMed=3198771; DOI=10.1172/JCI113839;
RA   Davidson B.L., Chin S.J., Wilson J.M., Kelley W.N., Palella T.D.;
RT   "Hypoxanthine-guanine phosphoribosyltransferase. Genetic evidence for
RT   identical mutations in two partially deficient subjects.";
RL   J. Clin. Invest. 82:2164-2167(1988).
RN   [30]
RP   VARIANTS DIRRANBANDI AND YERONGA.
RX   PubMed=3148064; DOI=10.1007/BF01800364;
RA   Keough D.T., Gordon R.B., Dejersey J., Emmerson B.T.;
RT   "Biochemical basis of hypoxanthine-guanine phosphoribosyltransferase
RT   deficiency in nine families.";
RL   J. Inherit. Metab. Dis. 11:229-238(1988).
RN   [31]
RP   VARIANTS LNS LEU-54 AND 179-GLY-ARG-180.
RX   PubMed=2572141;
RA   Igarashi T., Minami M., Nishida Y.;
RT   "Molecular analysis of hypoxanthine-guanine phosphoribosyltransferase
RT   mutations in five unrelated Japanese patients.";
RL   Acta Paediatr. Jpn. Overseas Ed. 31:303-313(1989).
RN   [32]
RP   VARIANT GOUT-HPRT ASHVILLE GLY-201.
RX   PubMed=2909537;
RA   Davidson B.L., Pashmforoush M., Kelly W.N., Palella T.D.;
RT   "Human hypoxanthine-guanine phosphoribosyltransferase deficiency. The
RT   molecular defect in a patient with gout (HPRTAshville).";
RL   J. Biol. Chem. 264:520-525(1989).
RN   [33]
RP   VARIANT LNS YALE ARG-71.
RX   PubMed=2910902; DOI=10.1172/JCI113846;
RA   Fujimori S., Davidson B.L., Kelley W.N., Palella T.D.;
RT   "Identification of a single nucleotide change in the hypoxanthine-
RT   guanine phosphoribosyltransferase gene (HPRTYale) responsible for
RT   Lesch-Nyhan syndrome.";
RL   J. Clin. Invest. 83:11-13(1989).
RN   [34]
RP   VARIANTS ARLINGEN; DETROIT; NEW BRITON AND NEW HAVEN.
RX   PubMed=2738157; DOI=10.1172/JCI114160;
RA   Davidson B.L., Tarle S.A., Palella T.D., Kelley W.N.;
RT   "Molecular basis of hypoxanthine-guanine phosphoribosyltransferase
RT   deficiency in ten subjects determined by direct sequencing of
RT   amplified transcripts.";
RL   J. Clin. Invest. 84:342-346(1989).
RN   [35]
RP   VARIANTS RKJ.
RX   PubMed=2928313; DOI=10.1073/pnas.86.6.1919;
RA   Gibbs R.A., Nguyen P.N., McBride L.J., Koepf S.M., Caskey C.T.;
RT   "Identification of mutations leading to the Lesch-Nyhan syndrome by
RT   automated direct DNA sequencing of in vitro amplified cDNA.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:1919-1923(1989).
RN   [36]
RP   VARIANTS LNS RJK LYS-45; LEU-74; ASP-130; SER-131; LYS-143; SER-161;
RP   TYR-177; ASN-194; VAL-199; ASP-204 AND TYR-206.
RX   PubMed=2347587; DOI=10.1016/0888-7543(90)90545-6;
RA   Gibbs R.A., Nguyen P.N., Edwards A., Civitello A.B., Caskey C.T.;
RT   "Multiplex DNA deletion detection and exon sequencing of the
RT   hypoxanthine phosphoribosyltransferase gene in Lesch-Nyhan families.";
RL   Genomics 7:235-244(1990).
RN   [37]
RP   VARIANT LNS MONTREAL THR-57.
RX   PubMed=2358296; DOI=10.1007/BF00276334;
RA   Skopek T.R., Recio L., Simpson D., Dallaire L., Melancon S.B.,
RA   Ogier H., O'Neill J.P., Falta M.T., Nicklas J.A., Albertini R.J.;
RT   "Molecular analyses of a Lesch-Nyhan syndrome mutation (hprtMontreal)
RT   by use of T-lymphocyte cultures.";
RL   Hum. Genet. 85:111-116(1990).
RN   [38]
RP   VARIANT LNS BRISBANE ILE-168.
RX   PubMed=2246854; DOI=10.1007/BF01799570;
RA   Gordon R.B., Sculley D.G., Dawson P.A., Beacham I.R., Emmerson B.T.;
RT   "Identification of a single nucleotide substitution in the coding
RT   sequence of in vitro amplified cDNA from a patient with partial HPRT
RT   deficiency (HPRTBRISBANE).";
RL   J. Inherit. Metab. Dis. 13:692-700(1990).
RN   [39]
RP   VARIANTS GRAVESEND; MASHAD; HEAPEY; BANBURY; RUNCORN; FARNHAM; MARLOW
RP   AND READING.
RX   PubMed=2018042;
RA   Davidson B.L., Tarle S.A., van Antwerp M., Gibbs D.A., Watts R.W.E.,
RA   Kelley W.N., Palella T.D.;
RT   "Identification of 17 independent mutations responsible for human
RT   hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency.";
RL   Am. J. Hum. Genet. 48:951-958(1991).
RN   [40]
RP   VARIANTS LNS TYR-28 DEL; VAL-50; GLU-70; LEU-74; THR-183 AND ARG-204.
RX   PubMed=2071157; DOI=10.1016/0888-7543(91)90341-B;
RA   Tarle S.A., Davidson B.L., Wu V.C., Zidar F.J., Seegmiller J.E.,
RA   Kelley W.N., Palella T.D.;
RT   "Determination of the mutations responsible for the Lesch-Nyhan
RT   syndrome in 17 subjects.";
RL   Genomics 10:499-501(1991).
RN   [41]
RP   VARIANTS PERTH; SWAN; TOOWONG AND URANGAN.
RX   PubMed=1937471; DOI=10.1007/BF00201727;
RA   Sculley D.G., Dawson P.A., Beacham I.R., Emmerson B.T., Gordon R.B.;
RT   "Hypoxanthine-guanine phosphoribosyltransferase deficiency: analysis
RT   of HPRT mutations by direct sequencing and allele-specific
RT   amplification.";
RL   Hum. Genet. 87:688-692(1991).
RN   [42]
RP   VARIANT ALA-188, AND NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 183-193.
RX   PubMed=1840476;
RA   Yamada Y., Goto H., Ogasawara N.;
RT   "Identification of two independent Japanese mutant HPRT genes using
RT   the PCR technique.";
RL   Adv. Exp. Med. Biol. 309B:121-124(1991).
RN   [43]
RP   VARIANT EDINBURGH GLY-52, AND NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1551676; DOI=10.1007/BF02265300;
RA   Lightfoot T., Joshi R., Nuki G., Snyder F.F.;
RT   "The point mutation of hypoxanthine-guanine phosphoribosyltransferase
RT   (HPRTEdinburgh) and detection by allele-specific polymerase chain
RT   reaction.";
RL   Hum. Genet. 88:695-696(1992).
RN   [44]
RP   VARIANTS, AND NUCLEOTIDE SEQUENCE [MRNA] OF 35-50.
RX   PubMed=1301916; DOI=10.1093/hmg/1.6.427;
RA   Sege-Paterson K., Chambers J., Page T., Jones O.W., Nyhan W.L.;
RT   "Characterization of mutations in phenotypic variants of hypoxanthine
RT   phosphoribosyltransferase deficiency.";
RL   Hum. Mol. Genet. 1:427-432(1992).
RN   [45]
RP   VARIANT GOUT-HPRT MOOSE JAW GLU-194, AND NUCLEOTIDE SEQUENCE.
RX   PubMed=7987318; DOI=10.1093/hmg/3.8.1377;
RA   Lightfoot T., Lewkonia R.M., Snyder F.F.;
RT   "Sequence, expression and characterization of HPRTMoose Jaw: a point
RT   mutation resulting in cooperativity and decreased substrate
RT   affinities.";
RL   Hum. Mol. Genet. 3:1377-1381(1994).
RN   [46]
RP   VARIANT LNS ISAR PHE-42.
RX   PubMed=7627191; DOI=10.1002/humu.1380050413;
RA   Burgemeister R., Roetzer E., Gutensohn W., Gehrke M., Schiel W.;
RT   "Identification of a new missense mutation in exon 2 of the human
RT   hypoxanthine phosphoribosyltransferase gene (HPRTIsar): a further
RT   example of clinical heterogeneity in HPRT deficiencies.";
RL   Hum. Mutat. 5:341-344(1995).
RN   [47]
RP   VARIANT ARG-61.
RX   PubMed=9003484; DOI=10.1007/s004390050300;
RA   Fujimori S., Sakuma R., Yamaoka N., Hakoda M., Yamanaka H.,
RA   Kamatani N.;
RT   "An asymptomatic germline missense base substitution in the
RT   hypoxanthine phosphoribosyltransferase (HPRT) gene that reduces the
RT   amount of enzyme in humans.";
RL   Hum. Genet. 99:8-10(1997).
RN   [48]
RP   VARIANT LNS ROANNE VAL-177.
RX   PubMed=9452051;
RA   Liu G., Aral B., Zabot M.-T., Kamoun P., Ceballos-Picot I.;
RT   "The molecular basis of hypoxanthine-guanine phosphoribosyltransferase
RT   deficiency in French families; report of two novel mutations.";
RL   Hum. Mutat. Suppl. 1:S88-S90(1998).
RN   [49]
RP   VARIANTS LNS PRO-64; PRO-65; GLU-70; CYS-72; GLN-78; PRO-147; GLU-159
RP   AND 107-ASN--SER-110 DEL, AND VARIANTS GOUT-HPRT ALA-188; VAL-192 AND
RP   CYS-195.
RX   PubMed=15571223; DOI=10.1081/NCN-200027439;
RA   Yamada Y., Yamada K., Sonta S., Wakamatsu N., Ogasawara N.;
RT   "Mutations in the hypoxanthine guanine phosphoribosyltransferase gene
RT   (HPRT1) in Asian HPRT deficient families.";
RL   Nucleosides Nucleotides Nucleic Acids 23:1169-1172(2004).
RN   [50]
RP   VARIANTS LNS VAL-8 DEL; TYR-28 DEL; PRO-64; PRO-65; GLU-70; CYS-72;
RP   GLN-78; PRO-147; GLU-159; VAL-159 INS AND ALA-188, AND VARIANTS
RP   GOUT-HPRT PRO-124; GLY-185; VAL-192 AND CYS-195.
RX   PubMed=17027311; DOI=10.1016/j.ymgme.2006.08.013;
RA   Yamada Y., Nomura N., Yamada K., Wakamatsu N.;
RT   "Molecular analysis of HPRT deficiencies: an update of the spectrum of
RT   Asian mutations with novel mutations.";
RL   Mol. Genet. Metab. 90:70-76(2007).
RN   [51]
RP   VARIANTS LNS TYR-44 AND LEU-74.
RX   PubMed=20544509; DOI=10.1080/15257771003738691;
RA   Yamada Y., Yamada K., Nomura N., Yamano A., Kimura R., Tomida S.,
RA   Naiki M., Wakamatsu N.;
RT   "Molecular analysis of two enzyme genes, HPRT1 and PRPS1, causing X-
RT   linked inborn errors of purine metabolism.";
RL   Nucleosides Nucleotides Nucleic Acids 29:291-294(2010).
RN   [52]
RP   INVOLVEMENT IN LNS, INVOLVEMENT IN GOUT-HPRT, VARIANTS GOUT-HPRT
RP   VAL-20; PHE-23 AND ARG-60, AND CHARACTERIZATION OF VARIANTS GOUT-HPRT
RP   VAL-20; PHE-23 AND ARG-60.
RX   PubMed=24940672; DOI=10.1080/15257770.2013.865743;
RA   Yamada Y., Nomura N., Yamada K., Kimura R., Fukushi D., Wakamatsu N.,
RA   Matsuda Y., Yamauchi T., Ueda T., Hasegawa H., Nakamura M., Ichida K.,
RA   Kaneko K., Fujimori S.;
RT   "Hypoxanthine guanine phosphoribosyltransferase (HPRT) deficiencies:
RT   HPRT1 mutations in new Japanese families and PRPP concentration.";
RL   Nucleosides Nucleotides Nucleic Acids 33:218-222(2014).
CC   -!- FUNCTION: Converts guanine to guanosine monophosphate, and
CC       hypoxanthine to inosine monophosphate. Transfers the 5-
CC       phosphoribosyl group from 5-phosphoribosylpyrophosphate onto the
CC       purine. Plays a central role in the generation of purine
CC       nucleotides through the purine salvage pathway.
CC   -!- CATALYTIC ACTIVITY: IMP + diphosphate = hypoxanthine + 5-phospho-
CC       alpha-D-ribose 1-diphosphate.
CC   -!- CATALYTIC ACTIVITY: GMP + diphosphate = guanine + 5-phospho-alpha-
CC       D-ribose 1-diphosphate.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC       Note=Binds 2 magnesium ions per subunit. The magnesium ions are
CC       essentially bound to the substrate and have few direct
CC       interactions with the protein.;
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=5.4 uM for IMP {ECO:0000269|PubMed:10338013};
CC         KM=0.45 uM for hypoxanthine {ECO:0000269|PubMed:10338013};
CC         KM=25 uM for pyrophosphate {ECO:0000269|PubMed:10338013};
CC         KM=31 uM for phosphoribosylpyrophosphate
CC         {ECO:0000269|PubMed:10338013};
CC   -!- PATHWAY: Purine metabolism; IMP biosynthesis via salvage pathway;
CC       IMP from hypoxanthine: step 1/1.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:10338013,
CC       ECO:0000269|PubMed:10360366, ECO:0000269|PubMed:15990111,
CC       ECO:0000269|PubMed:8044844}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-748210, EBI-748210;
CC       Q9H1K1:ISCU; NbExp=3; IntAct=EBI-748210, EBI-1047335;
CC       Q9NRG1:PRTFDC1; NbExp=9; IntAct=EBI-748210, EBI-739759;
CC       O00560:SDCBP; NbExp=5; IntAct=EBI-748210, EBI-727004;
CC       Q96HA8:WDYHV1; NbExp=8; IntAct=EBI-748210, EBI-741158;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- DISEASE: Lesch-Nyhan syndrome (LNS) [MIM:300322]: Characterized by
CC       complete lack of enzymatic activity that results in hyperuricemia,
CC       choreoathetosis, mental retardation, and compulsive self-
CC       mutilation. {ECO:0000269|PubMed:15571223,
CC       ECO:0000269|PubMed:17027311, ECO:0000269|PubMed:20544509,
CC       ECO:0000269|PubMed:2071157, ECO:0000269|PubMed:2246854,
CC       ECO:0000269|PubMed:2347587, ECO:0000269|PubMed:2358296,
CC       ECO:0000269|PubMed:24940672, ECO:0000269|PubMed:2572141,
CC       ECO:0000269|PubMed:2910902, ECO:0000269|PubMed:3265398,
CC       ECO:0000269|PubMed:3384338, ECO:0000269|PubMed:6853716,
CC       ECO:0000269|PubMed:7627191, ECO:0000269|PubMed:9452051}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Gout HPRT-related (GOUT-HPRT) [MIM:300323]: Characterized
CC       by partial enzyme activity and hyperuricemia.
CC       {ECO:0000269|PubMed:15571223, ECO:0000269|PubMed:17027311,
CC       ECO:0000269|PubMed:20544509, ECO:0000269|PubMed:24940672,
CC       ECO:0000269|PubMed:2896620, ECO:0000269|PubMed:2909537,
CC       ECO:0000269|PubMed:3198771, ECO:0000269|PubMed:3358423,
CC       ECO:0000269|PubMed:6572373, ECO:0000269|PubMed:6706936,
CC       ECO:0000269|PubMed:6853490, ECO:0000269|PubMed:7987318}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the purine/pyrimidine
CC       phosphoribosyltransferase family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/hprt1/";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Hypoxanthine-guanine
CC       phosphoribosyltransferase entry;
CC       URL="https://en.wikipedia.org/wiki/Hypoxanthine-guanine_phosphoribosyltransferase";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M31642; AAA52690.1; -; mRNA.
DR   EMBL; M26434; AAA36012.1; -; Genomic_DNA.
DR   EMBL; AK313435; BAG36226.1; -; mRNA.
DR   EMBL; BT019350; AAV38157.1; -; mRNA.
DR   EMBL; AY780550; AAV31777.1; -; Genomic_DNA.
DR   EMBL; AC004383; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471107; EAX11761.1; -; Genomic_DNA.
DR   EMBL; BC000578; AAH00578.1; -; mRNA.
DR   EMBL; M12452; AAA52691.1; -; Genomic_DNA.
DR   EMBL; S79313; AAB21289.1; -; Genomic_DNA.
DR   EMBL; L29383; AAB59391.1; -; mRNA.
DR   EMBL; L29382; AAB59392.1; -; mRNA.
DR   EMBL; S60300; AAC60591.2; -; mRNA.
DR   CCDS; CCDS14641.1; -.
DR   PIR; A32728; RTHUG.
DR   RefSeq; NP_000185.1; NM_000194.2.
DR   UniGene; Hs.412707; -.
DR   PDB; 1BZY; X-ray; 2.00 A; A/B/C/D=2-218.
DR   PDB; 1D6N; X-ray; 2.70 A; A/B=5-218.
DR   PDB; 1HMP; X-ray; 2.50 A; A/B=2-218.
DR   PDB; 1Z7G; X-ray; 1.90 A; A/B/C/D=2-218.
DR   PDB; 2VFA; X-ray; 2.80 A; A/B=49-160.
DR   PDB; 3GEP; X-ray; 2.60 A; A/B=2-218.
DR   PDB; 3GGC; X-ray; 2.78 A; A/B=2-218.
DR   PDB; 3GGJ; X-ray; 2.60 A; A/B=2-218.
DR   PDB; 4IJQ; X-ray; 2.00 A; A/B/C/D=2-218.
DR   PDB; 4KN6; X-ray; 2.73 A; A=3-218.
DR   PDB; 4RAB; X-ray; 2.26 A; A/B/C/D=2-218.
DR   PDB; 4RAC; X-ray; 2.05 A; A/B/C/D=2-218.
DR   PDB; 4RAD; X-ray; 2.00 A; A/B/C/D/E/F/G/H=2-218.
DR   PDB; 4RAN; X-ray; 2.55 A; A/B/C/D=2-218.
DR   PDB; 4RAO; X-ray; 1.87 A; A/B/C/D=2-218.
DR   PDB; 4RAQ; X-ray; 2.53 A; A/B/C/D=2-218.
DR   PDB; 5BRN; X-ray; 2.30 A; A/B/C/D=1-218.
DR   PDB; 5BSK; X-ray; 2.61 A; A/B/C/D=1-218.
DR   PDB; 5HIA; X-ray; 1.77 A; A/B/C/D=1-218.
DR   PDBsum; 1BZY; -.
DR   PDBsum; 1D6N; -.
DR   PDBsum; 1HMP; -.
DR   PDBsum; 1Z7G; -.
DR   PDBsum; 2VFA; -.
DR   PDBsum; 3GEP; -.
DR   PDBsum; 3GGC; -.
DR   PDBsum; 3GGJ; -.
DR   PDBsum; 4IJQ; -.
DR   PDBsum; 4KN6; -.
DR   PDBsum; 4RAB; -.
DR   PDBsum; 4RAC; -.
DR   PDBsum; 4RAD; -.
DR   PDBsum; 4RAN; -.
DR   PDBsum; 4RAO; -.
DR   PDBsum; 4RAQ; -.
DR   PDBsum; 5BRN; -.
DR   PDBsum; 5BSK; -.
DR   PDBsum; 5HIA; -.
DR   ProteinModelPortal; P00492; -.
DR   SMR; P00492; -.
DR   BioGrid; 109488; 27.
DR   IntAct; P00492; 15.
DR   MINT; MINT-1443310; -.
DR   STRING; 9606.ENSP00000298556; -.
DR   BindingDB; P00492; -.
DR   ChEMBL; CHEMBL2360; -.
DR   DrugBank; DB02309; 5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine.
DR   DrugBank; DB04356; 9-Deazaguanine.
DR   DrugBank; DB01632; Alpha-Phosphoribosylpyrophosphoric Acid.
DR   DrugBank; DB00993; Azathioprine.
DR   DrugBank; DB01033; Mercaptopurine.
DR   DrugBank; DB00352; Tioguanine.
DR   iPTMnet; P00492; -.
DR   PhosphoSitePlus; P00492; -.
DR   SwissPalm; P00492; -.
DR   BioMuta; HPRT1; -.
DR   DMDM; 123497; -.
DR   OGP; P00492; -.
DR   REPRODUCTION-2DPAGE; IPI00218493; -.
DR   EPD; P00492; -.
DR   MaxQB; P00492; -.
DR   PaxDb; P00492; -.
DR   PeptideAtlas; P00492; -.
DR   PRIDE; P00492; -.
DR   TopDownProteomics; P00492; -.
DR   DNASU; 3251; -.
DR   Ensembl; ENST00000298556; ENSP00000298556; ENSG00000165704.
DR   GeneID; 3251; -.
DR   KEGG; hsa:3251; -.
DR   UCSC; uc004exl.5; human.
DR   CTD; 3251; -.
DR   DisGeNET; 3251; -.
DR   GeneCards; HPRT1; -.
DR   GeneReviews; HPRT1; -.
DR   HGNC; HGNC:5157; HPRT1.
DR   HPA; CAB012200; -.
DR   HPA; HPA006360; -.
DR   MalaCards; HPRT1; -.
DR   MIM; 300322; phenotype.
DR   MIM; 300323; phenotype.
DR   MIM; 308000; gene.
DR   neXtProt; NX_P00492; -.
DR   OpenTargets; ENSG00000165704; -.
DR   Orphanet; 79233; Hypoxanthine guanine phosphoribosyltransferase partial deficiency.
DR   Orphanet; 510; Lesch-Nyhan syndrome.
DR   PharmGKB; PA29427; -.
DR   eggNOG; KOG3367; Eukaryota.
DR   eggNOG; COG0634; LUCA.
DR   GeneTree; ENSGT00390000017323; -.
DR   HOGENOM; HOG000236521; -.
DR   HOVERGEN; HBG000242; -.
DR   InParanoid; P00492; -.
DR   KO; K00760; -.
DR   OMA; DIAYVGF; -.
DR   OrthoDB; EOG091G0K6K; -.
DR   PhylomeDB; P00492; -.
DR   TreeFam; TF313367; -.
DR   BioCyc; MetaCyc:HS09275-MONOMER; -.
DR   BRENDA; 2.4.2.8; 2681.
DR   Reactome; R-HSA-74217; Purine salvage.
DR   SABIO-RK; P00492; -.
DR   UniPathway; UPA00591; UER00648.
DR   ChiTaRS; HPRT1; human.
DR   EvolutionaryTrace; P00492; -.
DR   GeneWiki; Hypoxanthine-guanine_phosphoribosyltransferase; -.
DR   GenomeRNAi; 3251; -.
DR   PRO; PR:P00492; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000165704; -.
DR   CleanEx; HS_HPRT1; -.
DR   ExpressionAtlas; P00492; baseline and differential.
DR   Genevisible; P00492; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0052657; F:guanine phosphoribosyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0004422; F:hypoxanthine phosphoribosyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0006168; P:adenine salvage; IEA:Ensembl.
DR   GO; GO:0021954; P:central nervous system neuron development; IEA:Ensembl.
DR   GO; GO:0021895; P:cerebral cortex neuron differentiation; IEA:Ensembl.
DR   GO; GO:0019835; P:cytolysis; IEA:Ensembl.
DR   GO; GO:0048813; P:dendrite morphogenesis; IEA:Ensembl.
DR   GO; GO:0042417; P:dopamine metabolic process; IEA:Ensembl.
DR   GO; GO:0046038; P:GMP catabolic process; IDA:UniProtKB.
DR   GO; GO:0007625; P:grooming behavior; IEA:Ensembl.
DR   GO; GO:0006178; P:guanine salvage; IDA:UniProtKB.
DR   GO; GO:0046100; P:hypoxanthine metabolic process; IMP:UniProtKB.
DR   GO; GO:0043103; P:hypoxanthine salvage; IDA:UniProtKB.
DR   GO; GO:0046040; P:IMP metabolic process; IDA:UniProtKB.
DR   GO; GO:0032264; P:IMP salvage; IEA:UniProtKB-UniPathway.
DR   GO; GO:0007626; P:locomotory behavior; IEA:Ensembl.
DR   GO; GO:0046651; P:lymphocyte proliferation; IEA:Ensembl.
DR   GO; GO:0045964; P:positive regulation of dopamine metabolic process; IMP:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:UniProtKB.
DR   GO; GO:0006164; P:purine nucleotide biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0006166; P:purine ribonucleoside salvage; IMP:UniProtKB.
DR   GO; GO:0043101; P:purine-containing compound salvage; TAS:Reactome.
DR   GO; GO:0001975; P:response to amphetamine; IEA:Ensembl.
DR   GO; GO:0021756; P:striatum development; IEA:Ensembl.
DR   CDD; cd06223; PRTases_typeI; 1.
DR   InterPro; IPR005904; Hxn_phspho_trans.
DR   InterPro; IPR000836; PRibTrfase_dom.
DR   InterPro; IPR029057; PRTase-like.
DR   Pfam; PF00156; Pribosyltran; 1.
DR   SUPFAM; SSF53271; SSF53271; 1.
DR   TIGRFAMs; TIGR01203; HGPRTase; 1.
DR   PROSITE; PS00103; PUR_PYR_PR_TRANSFER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Disease mutation; Glycosyltransferase;
KW   Gout; Isopeptide bond; Magnesium; Metal-binding; Nucleotide-binding;
KW   Phosphoprotein; Purine salvage; Reference proteome; Transferase;
KW   Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:7107641}.
FT   CHAIN         2    218       Hypoxanthine-guanine
FT                                phosphoribosyltransferase.
FT                                /FTId=PRO_0000139585.
FT   NP_BIND     134    142       GMP. {ECO:0000269|PubMed:8044844}.
FT   NP_BIND     186    188       GMP. {ECO:0000269|PubMed:8044844}.
FT   ACT_SITE    138    138       Proton acceptor. {ECO:0000305}.
FT   METAL       194    194       Magnesium.
FT   BINDING      69     69       GMP. {ECO:0000269|PubMed:8044844}.
FT   BINDING     166    166       GMP. {ECO:0000269|PubMed:8044844}.
FT   BINDING     194    194       GMP; via carbonyl oxygen.
FT                                {ECO:0000269|PubMed:8044844}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000269|PubMed:7107641}.
FT   MOD_RES     103    103       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P00493}.
FT   MOD_RES     142    142       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P27605}.
FT   CROSSLNK    115    115       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1).
FT                                {ECO:0000244|PubMed:25114211}.
FT   VARIANT       7      7       G -> D (in GOUT-HPRT; Gravesend).
FT                                /FTId=VAR_006750.
FT   VARIANT       8      8       V -> G (in LNS; HB).
FT                                /FTId=VAR_006751.
FT   VARIANT       8      8       Missing (in LNS; Asia).
FT                                {ECO:0000269|PubMed:17027311}.
FT                                /FTId=VAR_071609.
FT   VARIANT      16     16       G -> D (in LNS; FG).
FT                                /FTId=VAR_006752.
FT   VARIANT      16     16       G -> S (in GOUT-HPRT; Urangan;
FT                                dbSNP:rs137852499).
FT                                /FTId=VAR_006753.
FT   VARIANT      20     20       D -> V (in GOUT-HPRT; Mashad; strongly
FT                                reduces enzymatic activity).
FT                                {ECO:0000269|PubMed:24940672}.
FT                                /FTId=VAR_006754.
FT   VARIANT      23     23       C -> F (in GOUT-HPRT; Reduces enzymatic
FT                                activity). {ECO:0000269|PubMed:24940672}.
FT                                /FTId=VAR_071610.
FT   VARIANT      23     23       C -> W (in GOUT-HPRT; JS).
FT                                /FTId=VAR_006755.
FT   VARIANT      28     28       Missing (in LNS; Asia).
FT                                {ECO:0000269|PubMed:17027311,
FT                                ECO:0000269|PubMed:2071157}.
FT                                /FTId=VAR_012312.
FT   VARIANT      41     41       L -> P (in LNS; Detroit;
FT                                dbSNP:rs137852480).
FT                                /FTId=VAR_006756.
FT   VARIANT      42     42       I -> F (in LNS; Isar).
FT                                {ECO:0000269|PubMed:7627191}.
FT                                /FTId=VAR_006757.
FT   VARIANT      42     42       I -> T (in LNS; Heapey).
FT                                /FTId=VAR_006758.
FT   VARIANT      43     44       MD -> RN (in LNS; Salamanca).
FT                                /FTId=VAR_006759.
FT   VARIANT      44     44       D -> Y (in LNS; Japan).
FT                                {ECO:0000269|PubMed:20544509}.
FT                                /FTId=VAR_071611.
FT   VARIANT      45     45       R -> K (in LNS; RJK 2163;
FT                                dbSNP:rs137852491).
FT                                {ECO:0000269|PubMed:2347587}.
FT                                /FTId=VAR_006760.
FT   VARIANT      48     48       R -> H (in GOUT-HPRT; AD and DD;
FT                                dbSNP:rs387906725).
FT                                /FTId=VAR_006761.
FT   VARIANT      50     50       A -> P (in LNS; LW).
FT                                /FTId=VAR_006763.
FT   VARIANT      50     50       A -> V (in LNS; 1265).
FT                                {ECO:0000269|PubMed:2071157}.
FT                                /FTId=VAR_006762.
FT   VARIANT      51     51       R -> G (in GOUT-HPRT; Toronto;
FT                                dbSNP:rs137852494).
FT                                {ECO:0000269|PubMed:6853490}.
FT                                /FTId=VAR_006764.
FT   VARIANT      51     51       R -> P (in LNS; Banbury).
FT                                /FTId=VAR_006765.
FT   VARIANT      52     52       D -> G (in Edinburgh; dbSNP:rs137852502).
FT                                {ECO:0000269|PubMed:1551676}.
FT                                /FTId=VAR_006766.
FT   VARIANT      53     53       V -> A (in GOUT-HPRT; MG).
FT                                /FTId=VAR_006767.
FT   VARIANT      53     53       V -> M (in GOUT-HPRT; TE).
FT                                /FTId=VAR_006768.
FT   VARIANT      54     54       M -> L (in LNS; Japan-1).
FT                                {ECO:0000269|PubMed:2572141}.
FT                                /FTId=VAR_006769.
FT   VARIANT      57     57       M -> T (in LNS; Montreal;
FT                                dbSNP:rs137852495).
FT                                {ECO:0000269|PubMed:2358296}.
FT                                /FTId=VAR_006770.
FT   VARIANT      58     58       G -> R (in GOUT-HPRT; Toowong;
FT                                dbSNP:rs137852500).
FT                                /FTId=VAR_006771.
FT   VARIANT      60     60       H -> R (in GOUT-HPRT; Reduces enzymatic
FT                                activity). {ECO:0000269|PubMed:24940672}.
FT                                /FTId=VAR_071612.
FT   VARIANT      61     61       H -> R (enzyme activity 37% of normal;
FT                                asymptomatic).
FT                                {ECO:0000269|PubMed:9003484}.
FT                                /FTId=VAR_006772.
FT   VARIANT      64     64       A -> P (in LNS; Asia).
FT                                {ECO:0000269|PubMed:15571223,
FT                                ECO:0000269|PubMed:17027311}.
FT                                /FTId=VAR_071613.
FT   VARIANT      65     65       L -> P (in LNS; Asia).
FT                                {ECO:0000269|PubMed:15571223,
FT                                ECO:0000269|PubMed:17027311}.
FT                                /FTId=VAR_071614.
FT   VARIANT      70     70       G -> E (in LNS; New Haven/1510, Asia;
FT                                dbSNP:rs137852487).
FT                                {ECO:0000269|PubMed:15571223,
FT                                ECO:0000269|PubMed:17027311,
FT                                ECO:0000269|PubMed:2071157}.
FT                                /FTId=VAR_006773.
FT   VARIANT      71     71       G -> R (in LNS; Yale; dbSNP:rs137852488).
FT                                {ECO:0000269|PubMed:2910902}.
FT                                /FTId=VAR_006774.
FT   VARIANT      72     72       Y -> C (in LNS; Asia).
FT                                {ECO:0000269|PubMed:15571223,
FT                                ECO:0000269|PubMed:17027311}.
FT                                /FTId=VAR_071615.
FT   VARIANT      74     74       F -> L (in LNS; Flint/RJK 892/DW/Perth/
FT                                1522, Japan; dbSNP:rs137852481).
FT                                {ECO:0000269|PubMed:20544509,
FT                                ECO:0000269|PubMed:2071157,
FT                                ECO:0000269|PubMed:2347587,
FT                                ECO:0000269|PubMed:3384338}.
FT                                /FTId=VAR_006775.
FT   VARIANT      78     78       L -> Q (in LNS; Asia).
FT                                {ECO:0000269|PubMed:15571223,
FT                                ECO:0000269|PubMed:17027311}.
FT                                /FTId=VAR_071616.
FT   VARIANT      78     78       L -> V (in GOUT-HPRT; Swan;
FT                                dbSNP:rs137852501).
FT                                /FTId=VAR_006776.
FT   VARIANT      80     80       D -> V (in GOUT-HPRT; Arlington;
FT                                dbSNP:rs137852478).
FT                                /FTId=VAR_006777.
FT   VARIANT     104    104       S -> R (in GOUT-HPRT; Munich;
FT                                dbSNP:rs137852485).
FT                                {ECO:0000269|PubMed:3358423,
FT                                ECO:0000269|PubMed:6706936}.
FT                                /FTId=VAR_006778.
FT   VARIANT     107    110       Missing (in LNS; Asia).
FT                                {ECO:0000269|PubMed:15571223}.
FT                                /FTId=VAR_071617.
FT   VARIANT     110    110       S -> L (in GOUT-HPRT; London;
FT                                dbSNP:rs137852482).
FT                                {ECO:0000269|PubMed:3198771,
FT                                ECO:0000269|PubMed:6572373}.
FT                                /FTId=VAR_006779.
FT   VARIANT     124    124       T -> P (in GOUT-HPRT; Asia).
FT                                {ECO:0000269|PubMed:17027311}.
FT                                /FTId=VAR_071618.
FT   VARIANT     130    130       V -> D (in LNS; Midland/RJK 896;
FT                                dbSNP:rs137852483).
FT                                {ECO:0000269|PubMed:2347587,
FT                                ECO:0000269|PubMed:3265398}.
FT                                /FTId=VAR_006780.
FT   VARIANT     131    131       L -> S (in LNS; RJK 1784).
FT                                {ECO:0000269|PubMed:2347587}.
FT                                /FTId=VAR_006781.
FT   VARIANT     132    132       I -> M (in GOUT-HPRT; Ann-Arbor;
FT                                dbSNP:rs137852477).
FT                                {ECO:0000269|PubMed:2896620}.
FT                                /FTId=VAR_006782.
FT   VARIANT     132    132       I -> T (in LNS; Runcorn).
FT                                /FTId=VAR_006783.
FT   VARIANT     135    135       D -> G (in GOUT-HPRT; Yeronga).
FT                                /FTId=VAR_006784.
FT   VARIANT     143    143       M -> K (in LNS; RJK 1210;
FT                                dbSNP:rs137852496).
FT                                {ECO:0000269|PubMed:2347587}.
FT                                /FTId=VAR_006785.
FT   VARIANT     143    143       M -> MA (in LNS; RW).
FT                                /FTId=VAR_006786.
FT   VARIANT     147    147       L -> P (in LNS; Asia).
FT                                {ECO:0000269|PubMed:15571223,
FT                                ECO:0000269|PubMed:17027311}.
FT                                /FTId=VAR_071619.
FT   VARIANT     159    159       K -> E (in LNS; Asia).
FT                                {ECO:0000269|PubMed:15571223,
FT                                ECO:0000269|PubMed:17027311}.
FT                                /FTId=VAR_071620.
FT   VARIANT     159    159       K -> KV (in LNS; Asia).
FT                                {ECO:0000269|PubMed:17027311}.
FT                                /FTId=VAR_071621.
FT   VARIANT     161    161       A -> S (in GOUT-HPRT; Milwaukee/RJK 949;
FT                                dbSNP:rs137852484).
FT                                {ECO:0000269|PubMed:2347587}.
FT                                /FTId=VAR_006787.
FT   VARIANT     162    162       S -> R (in LNS; Farnham).
FT                                /FTId=VAR_006788.
FT   VARIANT     168    168       T -> I (in GOUT-HPRT; Brisbane;
FT                                dbSNP:rs137852498).
FT                                {ECO:0000269|PubMed:2246854}.
FT                                /FTId=VAR_006789.
FT   VARIANT     176    176       P -> L (in LNS; Marlow;
FT                                dbSNP:rs137852493).
FT                                /FTId=VAR_006790.
FT   VARIANT     177    177       D -> V (in LNS; Roanne).
FT                                {ECO:0000269|PubMed:9452051}.
FT                                /FTId=VAR_006791.
FT   VARIANT     177    177       D -> Y (in LNS; RJK 2185;
FT                                dbSNP:rs137852492).
FT                                {ECO:0000269|PubMed:2347587}.
FT                                /FTId=VAR_006792.
FT   VARIANT     179    180       VG -> GR (in GOUT-HPRT; Japan-2).
FT                                /FTId=VAR_006794.
FT   VARIANT     179    179       Missing (in LNS; Michigan).
FT                                /FTId=VAR_006793.
FT   VARIANT     183    183       I -> T (in GOUT-HPRT; JF).
FT                                {ECO:0000269|PubMed:2071157}.
FT                                /FTId=VAR_006796.
FT   VARIANT     185    185       D -> G (in GOUT-HPRT; Asia).
FT                                {ECO:0000269|PubMed:17027311}.
FT                                /FTId=VAR_071622.
FT   VARIANT     188    188       V -> A (in GOUT-HPRT AND LNS; Asia).
FT                                {ECO:0000269|PubMed:15571223,
FT                                ECO:0000269|PubMed:17027311,
FT                                ECO:0000269|PubMed:1840476}.
FT                                /FTId=VAR_006795.
FT   VARIANT     192    192       A -> V (in GOUT-HPRT; Asia).
FT                                {ECO:0000269|PubMed:15571223,
FT                                ECO:0000269|PubMed:17027311}.
FT                                /FTId=VAR_071623.
FT   VARIANT     194    194       D -> E (in GOUT-HPRT; Moose-Jaw; results
FT                                in cooperativity and decreased substrate
FT                                affinities; dbSNP:rs137852504).
FT                                {ECO:0000269|PubMed:7987318}.
FT                                /FTId=VAR_006797.
FT   VARIANT     194    194       D -> N (in LNS; Kinston/RJK 2188;
FT                                dbSNP:rs267606863).
FT                                {ECO:0000269|PubMed:2347587,
FT                                ECO:0000269|PubMed:6853716}.
FT                                /FTId=VAR_006798.
FT   VARIANT     195    195       Y -> C (in GOUT-HPRT; Dirranbandi, Asia).
FT                                {ECO:0000269|PubMed:15571223,
FT                                ECO:0000269|PubMed:17027311}.
FT                                /FTId=VAR_006799.
FT   VARIANT     199    199       F -> V (in LNS; New Briton/RJK 950;
FT                                dbSNP:rs137852486).
FT                                {ECO:0000269|PubMed:2347587}.
FT                                /FTId=VAR_006800.
FT   VARIANT     201    201       D -> G (in GOUT-HPRT; Ashville;
FT                                dbSNP:rs137852479).
FT                                {ECO:0000269|PubMed:2909537}.
FT                                /FTId=VAR_006801.
FT   VARIANT     201    201       D -> N (in GOUT-HPRT; RB).
FT                                /FTId=VAR_006802.
FT   VARIANT     201    201       D -> Y (in LNS; GM).
FT                                /FTId=VAR_006803.
FT   VARIANT     204    204       H -> D (in LNS; RJK 1874;
FT                                dbSNP:rs137852490).
FT                                {ECO:0000269|PubMed:2347587}.
FT                                /FTId=VAR_006804.
FT   VARIANT     204    204       H -> R (in LNS; 779).
FT                                {ECO:0000269|PubMed:2071157}.
FT                                /FTId=VAR_006805.
FT   VARIANT     206    206       C -> Y (in LNS; Reading/RJK 1727).
FT                                {ECO:0000269|PubMed:2347587}.
FT                                /FTId=VAR_006806.
FT   MUTAGEN      69     69       K->A: Reduced affinity for hypoxanthine,
FT                                phosphoribosylpyrophosphate and IMP.
FT                                Reduced catalytic activity.
FT                                {ECO:0000269|PubMed:10338013}.
FT   STRAND        7      9       {ECO:0000244|PDB:1HMP}.
FT   STRAND       12     14       {ECO:0000244|PDB:3GEP}.
FT   HELIX        19     21       {ECO:0000244|PDB:5HIA}.
FT   HELIX        26     28       {ECO:0000244|PDB:5HIA}.
FT   TURN         29     31       {ECO:0000244|PDB:5HIA}.
FT   STRAND       32     37       {ECO:0000244|PDB:5HIA}.
FT   HELIX        39     57       {ECO:0000244|PDB:5HIA}.
FT   STRAND       62     68       {ECO:0000244|PDB:5HIA}.
FT   TURN         69     71       {ECO:0000244|PDB:5HIA}.
FT   HELIX        72     87       {ECO:0000244|PDB:5HIA}.
FT   STRAND       88     90       {ECO:0000244|PDB:5HIA}.
FT   STRAND       95    101       {ECO:0000244|PDB:5HIA}.
FT   STRAND      109    118       {ECO:0000244|PDB:1BZY}.
FT   HELIX       119    121       {ECO:0000244|PDB:4RAC}.
FT   HELIX       123    125       {ECO:0000244|PDB:5HIA}.
FT   STRAND      128    140       {ECO:0000244|PDB:5HIA}.
FT   HELIX       141    150       {ECO:0000244|PDB:5HIA}.
FT   HELIX       151    153       {ECO:0000244|PDB:5HIA}.
FT   STRAND      156    166       {ECO:0000244|PDB:5HIA}.
FT   STRAND      169    171       {ECO:0000244|PDB:1Z7G}.
FT   STRAND      177    183       {ECO:0000244|PDB:5HIA}.
FT   STRAND      188    190       {ECO:0000244|PDB:5HIA}.
FT   STRAND      195    197       {ECO:0000244|PDB:5BSK}.
FT   STRAND      198    201       {ECO:0000244|PDB:1BZY}.
FT   STRAND      203    208       {ECO:0000244|PDB:5HIA}.
FT   HELIX       210    215       {ECO:0000244|PDB:5HIA}.
SQ   SEQUENCE   218 AA;  24579 MW;  1928EE69517CCB40 CRC64;
     MATRSPGVVI SDDEPGYDLD LFCIPNHYAE DLERVFIPHG LIMDRTERLA RDVMKEMGGH
     HIVALCVLKG GYKFFADLLD YIKALNRNSD RSIPMTVDFI RLKSYCNDQS TGDIKVIGGD
     DLSTLTGKNV LIVEDIIDTG KTMQTLLSLV RQYNPKMVKV ASLLVKRTPR SVGYKPDFVG
     FEIPDKFVVG YALDYNEYFR DLNHVCVISE TGKAKYKA
//
